Inhibitors of signal transduction protein kinases as targets for cancer therapy
Author:
Publisher
Elsevier
Reference249 articles.
1. The origins of protein phosphorylation;Cohen;Nat Cell Biol,2002
2. Tyrosine kinases as targets for cancer therapy;Krause;N Engl J Med,2005
3. Tyrosine kinase inhibitors and the dawn of molecular cancer therapeutics;Tibes;Annu Rev Pharmacol Toxicol,2005
4. The protein kinase complement of the human genome;Manning;Science,2002
5. Signal transduction pathways in cancer development and as targets for cancer prevention;Bode;Prog Nucl Acid Res Mol Biol,2005
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evolving strategies and application of proteins and peptide therapeutics in cancer treatment;Biomedicine & Pharmacotherapy;2023-07
2. Protein kinases on carbon metabolism: potential targets for alternative chemotherapies against toxoplasmosis;Frontiers in Cellular and Infection Microbiology;2023-05-23
3. Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders;Autoimmunity Reviews;2023-05
4. Novel pyrazole-based COX-2 inhibitors as potential anticancer agents: Design, synthesis, cytotoxic effect against resistant cancer cells, cell cycle arrest, apoptosis induction and dual EGFR/Topo-1 inhibition;Bioorganic Chemistry;2023-02
5. A Novel ERK2 Degrader Z734 Induces Apoptosis of MCF–7 Cells via the HERC3/p53 Signaling Pathway;Molecules;2022-07-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3